De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience

De novo cancers of head and neck area in solid organ transplantation recipients show standardized incidence ratio (SIR) of 3.8. Immunosuppression following transplantation is suggested to play as a crucial factor in pathogenesis of secondary malignancy. Prognosis of head and neck cancer arising in solid organ transplantation recipients is proven to have poor prognosis. The incidence, risk, prognosis, and survival of de novo malignancy of head and neck area in solid organ transplantation recipients in single-tertiary medical center followed up for 20 years.

from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2hsAqmv
via IFTTT